Company / Return on Assets (ROA)
Cytek Biosciences, Inc. Return on Assets (ROA) History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
-14.4%
FY2025
5-year range
-14.4% / 4.2%
FY2021-FY2025
Trend
-1091.7%
vs FY2024
Sector context
#136 of 159
Health Care
What the data says
Return on Assets (ROA) changed -1092% YoY in FY2025, a notable deviation from the 5-year average annual change of -359%.
Based on SEC 10-K filings.
-14.4% in FY2025 with a 5-year CAGR of -23.2%.
Declined from -2.5% to -14.4% over the past 2 years.
Health Care sector context is included.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- -14.9pp
- 5-Year Change
- -23.2pp
- 10-Year Change
- -
Sector benchmark
Bottom 14% in Health CareTop 86% of 159This company -14.4% Sector average -2.2%
▼
-551.9% below sector average
Key checks
Key Insights
- In FY2025, return on assets (roa) decreased 1091.7% year-over-year.
- Currently 12.2pp below the Health Care sector average.
- Peak return on assets (roa) was recorded in FY2020.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -14.4% | -1091.7% |
| FY2024 | -1.2% | +50.8% |
| FY2023 | -2.5% | -612.5% |
| FY2022 | 0.5% | -88.5% |
| FY2021 | 4.2% | -52.5% |
| FY2020 | 8.8% | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026